Assessing pneumococcal revaccination safety among New York State Medicare beneficiaries

Public Health Reports

Volumn 117, Issue 2, 2002, Pages 164-173

  Shih, Anthony ^a,b   Quinley, John ^a   Lee, Ti Kuang ^a   Messina, Catherine R ^b  

^a IPRO Inc   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGED; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; EDEMA; EMERGENCY WARD; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INFECTION; LIMB DISEASE; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICARE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PAIN; PRIORITY JOURNAL; RASH; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; REVACCINATION; SIDE EFFECT; SKIN SENSATION; STREPTOCOCCUS INFECTION; UNITED STATES; URTICARIA;

EID: 0036522233     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3549(04)50123-1     Document Type: Article

References (21)

1. Nuroti PJ, Butler JC, Brieman RF. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46:1-24.
2. Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, et al. Efficacy of pneumococcal vaccination in adults. Arch Intern Med 1994;154:2666-77.
3. Nichol KL, MacDonald R, Hauge M. Side effects associated with pneumococcal vaccination. Am J Infect Control 1997;25:223-8.
4. Fiebach N, Beckett W. Prevention of respiratory infections in adults: influenza and pneumococcal vaccines. Arch Intern Med 1994;154:2545-57.
5. Spika JS, Fedson DS, Facklam RR. Pneumococcal vaccination: controversies and opportunities. Infect Dis Clin North Am 1990;4:11-27.
6. Carlson AJ, Davidson WL, McLean AA, Vela PP, Weibel RE, Woodhour AF, et al. Pneumococcal vaccine: dose, revaccination, and coadministration with influenza vaccine. Proc Soc Exp Biol Med 1979;161:558-63.
7. Borgono JM, Mclean AA, Vella PP, Woodhour AF, Canepa I, Davidson WL, et al. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc Soc Exp Biol Med 1978;157:148-54.
8. Hilleman MR, Carlson AJ, Mclean AA, Vella PP, Weibel RE, Woodhour AF. Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. Rev Infect Dis 1981;3 Suppl:S31-S42.
9. Kaplan J, Sarnaik S, Schiffman G. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia. Am J Pediatr Hematol Oncol 1986;8:80-2.
10. Rutherford EJ, Livengood J, Higginbotham M, Miles WS, Koestner J, Edwards KM, et al. Efficacy and safety of pneumococcal revaccination after splenectomy for trauma. J Trauma 1995;39:448-52.
11. Mufson MA, Hughey DF, Turner CE, Schiffman G. Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination. Vaccine 1991;9:403-7.
12. Davidson M, Bulkow LR, Grabman J, Parkinson AJ, Chamblee C, Williams WW, et al. Immunogenicity of pneumococcal revaccination in patients with chronic disease. Arch Intern Med 1994;154:2209-14.
13. Rodriguez R, Dyer PD. Safety of pneumococcal revaccination. J Gen Intern Med 1995;10:511-12.
14. Jackson LA, Benson P, Sneller VP, Butler JC, Thompson RS, Chen RT, et al. Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA 1999;281:243-8.
15. Snow RS, Babish JD, McBean AM. Is there any connection between a second pneumonia shot and hospitalization among Medicare beneficiaries? Public Health Rep 1995;110:720-5.
16. Department of Health and Human Services (US). International classification of diseases, ninth revision, clinical modification. 6th ed. Washington: DHHS; 1996.
17. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity, in longitudinal studies: development and validation. J Chron Dis 1987;40:373-83.
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19.
19. Centers for Disease Control and Prevention (US). Epilnfo: version 6. Atlanta: CDC; 1994.
20. SPSS Inc. SPSS: version 9.0. Chicago: SPSS Inc.; 1999.
21. Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion, Division of Adult and Community Health, Behavioral Surveillance Branch. 1999 BRFSS summary prevalence report. June 2000 [cited 2002 May 13]. Available from: URL: http://www.cdc.gov/nccdphp/brfss/pdf/99prvrpt.pdf